9989830 |
High frequency of p16INK4A gene alterations in hepatocellular carcinoma
Liew, CT,
Wu, S,
Lau, WY,
Lee, JC,
Lim, BK,
Hin, LY,
Leow, CK,
Leung, WT,
Li, HM,
Lo, KW,
Chan, JY,
Lai, PB,
Huang, J
|
Oncogene |
1999 |
10389768 |
Functional reassessment of P16 variants using a transfection-based assay
Gabrielli, BG,
Castellano, M,
Walker, GJ,
Hayward, NK
|
Int. J. Cancer |
1999 |
19260062 |
Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients
Lenoir, GM,
Kannengiesser, C,
Brookes, S,
Chompret, A,
Pham, D,
Barrois, M,
Mauffret, O,
Sarasin, A,
del Arroyo, AG,
Bombled, J,
Avril, MF
|
Hum. Mutat. |
2009 |
24659262 |
CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment
Menin, C,
Agata, S,
Ghiorzo, P,
Quaggio, M,
Bianchi-ScarrĂ , G,
Zullato, D,
Pastorino, L,
Minervini, G,
Elefanti, L,
Scaini, MC,
Montagna, M,
Tognazzo, S,
Tosatto, SC,
D'Andrea, E
|
Hum. Mutat. |
2014 |
20340136 |
Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A
Mann, GJ,
Becker, TM,
Rizos, H,
McKenzie, HA,
Kefford, RF,
Fung, C,
Irvine, M
|
Hum. Mutat. |
2010 |
10380936 |
Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas
Lundh Rozell, B,
Kumar, R,
Hemminki, K,
Smeds, J
|
Melanoma Res. |
1999 |
17909018 |
A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6
Peters, G,
Jones, R,
Delia, D,
Moulin, S,
Brookes, S,
Manoukian, S,
Ruas, M,
Gregory, F,
Rowe, J
|
Cancer Res. |
2007 |
9354451 |
CDKN2A/p16 is inactivated in most melanoma cell lines
Sparrow, LE,
Gabrielli, BG,
Parsons, PG,
Pollock, PM,
Castellano, M,
Walters, MK,
Down, LM,
Hayward, NK
|
Cancer Res. |
1997 |
21053367 |
C-terminal domain of p16(INK4a) is adequate in inducing cell cycle arrest, growth inhibition and CDK4/6 interaction similar to the full length protein in HT-1080 fibrosarcoma cells
Fahham, N,
Ostad, SN,
Sardari, S,
Vaziri, B,
Ghahremani, MH
|
J. Cell. Biochem. |
2010 |
10498896 |
Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information
Peters, G,
McDonald, NQ,
Ruas, M,
Brookes, S
|
Oncogene |
1999 |
10491434 |
Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors
Bessho, M,
Buckmire, RA,
Liu, ET,
Yarbrough, WG
|
J. Natl. Cancer Inst. |
1999 |
9328469 |
Germline mutations of the CDKN2 gene in UK melanoma families
Frischauf, AM,
Brookes, S,
Gruis, N,
Selby, P,
Peters, G,
Bataille, V,
Meloni, R,
Bishop, JN,
Harland, M,
Bishop, DT,
Pinney, E,
Cuzick, J,
Spurr, NK
|
Hum. Mol. Genet. |
1997 |
27899578 |
COSMIC: somatic cancer genetics at high-resolution
Sondka, Z,
Bamford, S,
Campbell, PJ,
De, T,
Kok, CY,
Ponting, L,
Thompson, S,
Jubb, H,
Tate, J,
Beare, D,
Ward, S,
Cole, CG,
Harsha, B,
Boutselakis, H,
Bindal, N,
Dawson, E,
Forbes, SA,
Stefancsik, R,
Jia, M
|
Nucleic Acids Res. |
2017 |
11595726 |
Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding
Mann, GJ,
Kefford, RF,
Rizos, H,
Becker, TM
|
Clin. Cancer Res. |
2001 |
8153634 |
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A,
Day, RS,
Skolnick, MH,
Weaver-Feldhaus, J,
Stockert, E,
Gruis, NA,
Tavtigian, SV,
Johnson, BE,
Liu, Q,
Harshman, K
|
Science |
1994 |